Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

2013/02/04 by Michele D Tameris, Michèle Tameris, Mark Hatherill +16 · 4 citations
Immunology and Microbiology · Medicine · #Immune responses and vaccinations #Immunodeficiency and Autoimmune Disorders #Tuberculosis Research and Epidemiology

paper · pdf · doi:10.1016/s0140-6736(13)60177-4

openalex publication_date 2013/02/04 · crossref created 2013/02/04 · crossref issued 2013/03/01 · crossref published 2013/03/01 · crossref published-print 2013/03/01 · crossref deposited 2025/09/26 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/30

Citations

• Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
• Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis
• Variation in protection by BCG: implications of and for heterologous immunity

Cited by

• Vaccines for the 21st century
• The contribution of vaccination to global health: past, present and future
• Viral vectors as vaccine platforms: from immunogenicity to impact
• Genetically modified organism [wikipedia]